✦ LIBER ✦

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

✍ Scribed by Sara M Tinsley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Generation Tyrosine Kinase Inhibi

✍ Abruzzese, Elisabetta; Breccia, Massimo; Latagliata, Roberto 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 451 KB

Erratum to: Second-Generation Tyrosine K

✍ Abruzzese, Elisabetta; Breccia, Massimo; Latagliata, Roberto 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 125 KB

Clinical impact of dose reductions and i

✍ Fabio P. S. Santos; Hagop Kantarjian; Carmen Fava; Susan O’Brien; Guillermo Garc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

PP005—Risk perception and compliance in

✍ Burdová, K.; Friedecký, D.; Faber, E.; Strojil, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Pregnancies in patients with chronic mye

✍ Zhou, Li; You, Jian-Hua; Wu, Wen; Li, Jun-Min; Shen, Zhi-Xiang; Wang, Ai-Hua 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 373 KB

A Comparison of Methodologies for Estima

✍ Pennington, B.; Batty, A.J.; Clifton-Brown, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB